A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis
Abstract The B-cell lymphoma-2 (Bcl-2) family proteins, key regulators of apoptosis, are frequently dysregulated in cancer, tipping the balance of cell survival and apoptosis in favor of survival. The ubiquitin-proteasome system (UPS) is a critical cellular machinery that controls the Bcl-2 levels t...
Saved in:
| Main Authors: | Sourabh Soni, Vandana Anang, Yutong Zhao, Jeffrey C. Horowitz, Richard S. Nho, Yohannes A. Mebratu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03505-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRIM22 promotes glioblastoma development by ubiquitinating Bcl-2
by: Jiahao Zhang, et al.
Published: (2025-12-01) -
Polyamines directly promote antizyme-mediated degradation of ornithine decarboxylase by the proteasome
by: R. Roshini Beenukumar, et al.
Published: (2015-05-01) -
Role of the ubiquitin-proteasome system in the progression of oral squamous cell carcinoma
by: D. E. Mikhalev, et al.
Published: (2021-07-01) -
Proteasome dynamics in response to metabolic changes
by: Cordula Enenkel, et al.
Published: (2025-03-01) -
ROLE OF UBIQUITIN PROTEASOME SYSTEM IN GASTRIC CANCER PATHOGENESIS
by: E. V. Ivanova, et al.
Published: (2016-02-01)